Xiufeng Lin

No ORCID on file · 5 papers in corpus
other 2026
Comparison of tubal reanastomosis and in vitro fertilisation for restoring fertility in women with a history of tubal ligation
BMC pregnancy and childbirth ·doi:10.1186/s12884-026-08802-1

OBJECTIVE: To evaluate and compare the efficacy of tubal reanastomosis and in vitro fertilisation in achieving reproductive success in women who had undergone tubal ligation and desired additional children. METHODS: This study included 152…

other 2026
Gonadotropin-releasing hormone agonist (GnRH-a) pretreatment duration and letrozole supplementation for optimizing live birth rates in women with adenomyosis undergoing frozen-thawed embryo transfer (GOLD-FET): study protocol for a multicenter, 2 × 2 factorial randomized controlled trial in China
Trials ·doi:10.1186/s13063-026-09731-2

BACKGROUND: Adenomyosis, an estrogen-dependent condition characterized by endometrial invasion into the myometrium, is associated with reduced live birth rates and increased miscarriage risk in women undergoing assisted reproductive technol…

observational 2026
Paternal age and sperm DNA fragmentation independently affect embryonic ploidy but not euploid embryo implantation potential
Frontiers in endocrinology ·doi:10.3389/fendo.2026.1881113

OBJECTIVE: To systematically evaluate the associations between paternal factors (age, semen parameters, body mass index, sperm DNA fragmentation index (DFI), and leukocyte count), embryonic ploidy, and the clinical implantation potential of…

observational 2025
Effectiveness of preimplantation genetic testing for aneuploidy in improving clinical and neonatal outcomes for patients with recurrent pregnancy loss
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1690361

OBJECTIVES: This study aimed to evaluate a clinical utility of preimplantation genetic testing for aneuploidy (PGT-A) in patients with recurrent pregnancy loss (RPL) and explore a population that benefits from it. METHODS: We analyzed 818 …

observational 2023
Effects of reduced follicle-stimulating hormone dosage before human chorionic gonadotropin trigger on in vitro fertilization outcomes
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05943-5

OBJECTIVE: To determine whether a reduced dose of follicle-stimulating hormone (FSH) before human chorionic gonadotropin (hCG) trigger during ovarian stimulation can affect in vitro fertilization (IVF) outcomes. METHODS: This study include…